Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0TH8E
|
||||
Former ID |
DNC013078
|
||||
Drug Name |
M3P6S
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528255] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H27NO7S
|
||||
Canonical SMILES |
CC(C)(C)C(=O)OC1=C2C3=C(CC4C5C3(CCN4C)C(O2)C(C=C5)OS(=O<br />)(=O)O)C=C1
|
||||
InChI |
1S/C22H27NO7S/c1-21(2,3)20(24)28-15-7-5-12-11-14-13-6-8-16(30-31(25,26)27)19-22(13,9-10-23(14)4)17(12)18(15)29-19/h5-8,13-14,16,19H,9-11H2,1-4H3,(H,25,26,27)/t13-,14+,16-,19-,22-/m0/s1
|
||||
InChIKey |
NEUKRIIKAHFBFQ-JYSMHPMOSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [528255] | |
Kappa-type opioid receptor | Target Info | Inhibitor | [528255] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.